Amgen Inc. (0R0T)
LSE
Real-time Data
07:00 AM
Day's Range
437.5652 wk Range
270.92Overview - 0R0T - Amgen Inc.
Key Statistics
Valuation
Enterprise Value
177.06B
P/E (Trailing)
‪19.38‬
PEG Ratio
‪0.29‬
Price / Sales (TTM)
‪5.93‬
Price / Book
‪22.68‬
EV / EBITDA
‪12.86‬
Profitability
Gross Margin
‪72.04%‬
Profit Margin
‪30.01%‬
Operating Margin
‪38.44%‬
Return on Assets
‪8.54%‬
Return on Equity
‪173.45%‬
Ownership
Shares Outstanding
541.00M
Float
533.75M
Held by Insiders
‪0.23%‬
Held by Institutions
‪79.32%‬
Price stats
Beta
‪0.57‬
50-Day Avg
‪378.23‬
200-Day Avg
‪353.59‬
Dividends
Payout Ratio
‪54.85%‬
Frequency
Quarterly
Market Cap - 0R0T - Amgen Inc.
Peers - 0R0T - Amgen Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
- 0R0TLSEAmgen Inc.233.39BMarket Cap+34.05%52-week change19.38P/E (Trailing)‪30.01%‬Profit Margin
- AZNLSEAstraZeneca PLC22.41TMarket Cap+29.32%52-week change28.74P/E (Trailing)‪17.18%‬Profit Margin
- GSKLSEGSK plc7.68TMarket Cap+23.40%52-week change16.26P/E (Trailing)‪14.52%‬Profit Margin
- 0QIULSENovo Nordisk A/S1.24TMarket Cap-23.24%52-week change19.95P/E (Trailing)‪33.39%‬Profit Margin
- 0Q1GLSEEli Lilly and Company686.33BMarket Cap+54.90%52-week change1.56P/E (Trailing)‪33.52%‬Profit Margin
- 0QCVLSEAbbVie Inc.478.52BMarket Cap+21.83%52-week change54.73P/E (Trailing)‪15.50%‬Profit Margin
- 0QAHLSEMerck & Co., Inc.383.85BMarket Cap+44.02%52-week change63.23P/E (Trailing)‪5.33%‬Profit Margin
Profile Summary - 0R0T - Amgen Inc.
About
Amgen Inc. is a leading biotechnology company that discovers, develops, manufactures, and delivers human therapeutics worldwide. Its principal products target serious illnesses, including Enbrel for rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for plaque psoriasis, psoriatic arthritis, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
